We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca, Heptares Collaborating to Develop Cancer Treatments
AstraZeneca, Heptares Collaborating to Develop Cancer Treatments
AstraZeneca is planning to test at least one A2A receptor-blocking compound across a range of cancers, including in combination with the company’s existing immunotherapy portfolio, under a new collaboration with Heptares Therapeutics.